| Snapshots of CS cleavage in Egt2 reveals substrate specificity and reaction mechanism S Irani, N Naowarojna, Y Tang, KR Kathuria, S Wang, A Dhembi, N Lee, ... Cell chemical biology 25 (5), 519-529. e4, 2018 | 36 | 2018 |
| Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection F Gao, V Mallajosyula, PS Arunachalam, K van der Ploeg, M Manohar, ... Immunity 56 (4), 864-878. e4, 2023 | 34* | 2023 |
| Tyr1 phosphorylation promotes phosphorylation of Ser2 on the C-terminal domain of eukaryotic RNA polymerase II by P-TEFb JE Mayfield, S Irani, EE Escobar, Z Zhang, NT Burkholder, MR Robinson, ... Elife 8, e48725, 2019 | 28 | 2019 |
| Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling SK Alig, M Shahrokh Esfahani, A Garofalo, MY Li, C Rossi, T Flerlage, ... Nature 625 (7996), 778-787, 2024 | 8 | 2024 |
| Distinct molecular subtypes of classic Hodgkin lymphoma identified by comprehensive noninvasive profiling SK Alig, M Shahrokh Esfahani, MY Li, RM Adams, A Garofalo, MC Jin, ... Blood 140 (Supplement 1), 1295-1296, 2022 | 6 | 2022 |
| Distinct Hodgkin lymphoma subtypes identified by noninvasive genomic profiling SK Alig, M Shahrokh Esfahani, A Garofalo 17th International Conference on Malignant Lymphoma, 2023 | 2 | 2023 |
| Viral cfDNA profiling reveals distinct EBV subtypes and stratifies risk in Hodgkin lymphomas A Garofalo, SK Alig, J Schroers-Martin, RM Shyam, M Olsen, DM Kurtz, ... Blood 140 (Supplement 1), 1318-1319, 2022 | 2 | 2022 |
| Maria-I: a deep-learning approach for accurate prediction of MHC Class I tumor neoantigen presentation KR Kathuria, B Chen, MS Khodadoust, N Olsson, MM Davis, JE Elias, ... Blood 134, 84, 2019 | 2 | 2019 |
| Tyr1 phosphorylation promotes the phosphorylation of Ser2 on the C-terminal domain of RNA polymerase II by P-TEFb JE Mayfield, S Irani, EE Escobar, Z Zhang, NT Burkholder, MR Robinson, ... bioRxiv, 652214, 2019 | 2 | 2019 |
| Examining the mechanism of Egt2 in ergothioneine biosynthesis KR Kathuria, S Irani, P Liu, Y Zhang The FASEB Journal 31, 606.8-606.8, 2017 | 1 | 2017 |
| Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas ND Shukla, JG Schroers-Martin, BJ Sworder, KR Kathuria, SK Alig, ... Blood Advances 8 (3), 780-784, 2024 | | 2024 |
| Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods SK Alig, M Shahrokh Esfahani, A Garofalo, MY Li, C Rossi, T Flerlage, ... Blood 142 (Supplement 1), 177-177, 2023 | | 2023 |
| Single-cell sequencing of PBMC characterizes a distinct inflammatory monocyte subset in Lyme disease patients with Post-Treatment Lyme Disease Syndrome (PTLD) X Chen, X Zhou, X Ji, M Miranda, A Rebman, K Kathuria, WH Robinson, ... The Journal of Immunology 210 (1_Supplement), 155.18-155.18, 2023 | | 2023 |
| Robust T Cell Responses to the Pfizer/BioNTech Vaccine Compared to Infection and Evidence of Attenuated CD8 T Cell Responses Due to COVID-19 F Gao, V Mallajoysula, P Arunachalam, K van der Ploeg, M Manohar, ... | | 2023 |
| Specificity & Precision of Minimal Residual Disease Monitoring in DLBCL Using Ig-HTS ND Shukla, J Schroers-Martin, KR Kathuria, B Sworder, SK Alig, MJ Frank, ... Blood 140 (Supplement 1), 6403-6404, 2022 | | 2022 |
| Methods and Systems for Identification of Human Leukocyte Antigen Peptide Presentation and Applications Thereof AA Alizadeh, RB Altman, B Chen, KR Kathuria US Patent App. 16/943,951, 2021 | | 2021 |
| Tyr1 phosphorylation of RNA polymerase II CTD directs and expands the CTD code. JE Mayfield, MR Mehaffey, S Irani, L Walker, M Robinson, NT Burkholder, ... The FASEB Journal 32, 522.8-522.8, 2018 | | 2018 |
Seema IraniMemorial Sloan Kettering Cancer CenterVerified email at utexas.edu
